You are here: Industry Insights > CRISPR

News List

Oxford Genetics wins six licensing deals pharmatimes
April 04, 2019
In the last twelve months, Oxford Genetics has won six new licensing deals for its scalable gene therapy manufacturing technologies.
CRISPR gene editing stocks fall after Editas CEO resigns pharmaphorum
January 24, 2019
Shares in firms developing therapies based on CRISPR gene editing technology have fallen after the resignation of the CEO of one of the leading biotechs in the field, Editas.
Gene-editing tool CRISPR repurposed to develop better antibiotics expressbpd
January 15, 2019
The technique, known as Mobile-CRISPRi, allows scientists to screen for antibiotic function in a wide range of pathogenic bacteria
Janssen signs a $818m CRISPR products deal with Locus Biosciences pharmaceutical-technology
January 08, 2019
Janssen Pharmaceuticals has signed an exclusive collaboration and licence agreement with biotechnology firm Locus Biosciences for CRISPR products intended to treat bacterial infections.
Janssen signs a $818m CRISPR products deal with Locus Biosciences pharmaceutical-technology
January 07, 2019
Janssen Pharmaceuticals has signed an exclusive collaboration and licence agreement with biotechnology firm Locus Biosciences for CRISPR products intended to treat bacterial infections.....
GenEdit reels in $8.5M to tackle delivery for gene therapy, gene editing fiercebiotech
December 27, 2018
In October last year, a team of UC Berkeley scientists reported a new, nonviral CRISPR-delivery system that might address safety concerns with the gene-editing technology.....
CRISPR-based heart test pinpoints genetic risk for severe cardiomyopathy fiercebiotech
December 27, 2018
Severe hypertrophic cardiomyopathy, a dangerous disorder that causes an abnormal thickening of the heart walls, can run in families—and it’s often associated with a variant in the gene TNNT2.....
Mission Bio reels in $30M for single-cell genomics tech for oncology, CRISPR fiercebiotech
December 26, 2018
Since launching at the end of 2017 with a focus on blood cancers, Mission Bio has built out its single-cell genomics platform to include custom offerings....
CRISPR controls obesity in mice by amplifying rather than editing genes fiercebiotech
December 26, 2018
The genes SIM1 and MC4R regulate food intake by signaling the feeling of being full, which is why mutations in those genes are associated with severe obesity.....
AZ and CRUK team up to go all-in on CRISPR pharmaphorum
December 11, 2018
AstraZeneca and Cancer Research UK are collaborating to launch a centre of excellence in genetic screening, cancer modelling and big data processing that will develop CRISPR technology to better understand the biology of cancer.

Previous page 1 2 3 4 5 6 7 8 Next page